成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司名稱: 上海一飛生物科技有限公司
電話: 021-65675885
電子郵件:customer_service@efebio.com
國(guó)籍:中國(guó)
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11973
82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

Minalrestat 129688-50-2
H-Ile-Lys-Val-Ala-Val-OH 131167-89-0
Vinaxanthone 133293-89-7
Sitagliptin fenilalanil hydrochloride 1339954-75-4
LY2881835 1292290-38-0
PERK-IN-2 1337531-83-5
PKR-IN-C51 1314594-23-4
WY-47766 134217-27-9
Imifoplatin 1339960-28-9
Cavutilide 1276186-19-6
Ebaresdax hydrochloride 1334385-87-3
Besipirdine hydrochloride 130953-69-4
Lesopitron HCl 132449-88-8
3,5,6-trihydroxysitostane 133697-68-4
Vamicamide 132373-81-0
Cdc7-IN-7c 1330781-04-8
5-A-RU hydrochloride 134452-11-2
Compound 10w 1336890-05-1
Nesvacumab 1296818-77-3
Inebilizumab 1299440-37-1
Fallaxsaponin A 1287702-60-6
CYM50374 1314212-81-1
(-)-Vorozole 132042-69-4
ML089 1306638-12-9
Endomorphin 1 acetate 1276123-71-7
hGPR91 antagonist 3 1314796-31-0
(Rac)-Sabcomeline HCl 133642-67-8
Enzaplatovir 1323077-89-9
GSK854 1316059-00-3
EBOV-IN-1 1335113-30-8
Butyl chlorogenate 132741-56-1
PFM39 1310744-67-2
Concizumab 1312299-39-0
Anifrolumab 1326232-46-5
Iothalamate meglumine 13087-53-1
SAR247799 1315311-14-8
Antifolate C2 1286279-90-0
(E/Z)-Zotiraciclib hydrochloride 1321626-25-8
Maslimomab 127757-92-0
Sitagliptin fenilalanil 1339955-03-1
SRI 6409-94 127697-58-9
ABzOH 1313028-09-9
Rucaparib camsylate 1327258-57-0
Quilseconazole 1340593-70-5
Tubulin inhibitor 8 1309925-39-0
Orticumab 1314241-10-5
Pinatuzumab vedotin 1313706-14-7
HMBR 1287651-36-8
Dalvastatin 132100-55-1
Nemazoline Free Base 130759-56-7
Safironil 134377-69-8
Vorozole 129731-10-8
Bocconoline 1322007-90-8
Lecimibide 130804-35-2
KAT modulator-1 1314006-43-3
Chloroprocaine 133-16-4
Ampelopsin A 130608-11-6
Syk-IN-3 1312534-69-2
Ozanezumab 1310680-64-8
ALM301 1313439-71-2
TRC160334 1293289-69-6
HPPE 1325721-55-8
Soretolide 130403-08-6
Rilmakalim 132014-21-2
MK 0434 134067-56-4
PERK-IN-6 1337532-14-5
PLH1215 1332084-64-6
Lampalizumab 1278466-20-8
Simtuzumab 1318075-13-6
Tildrakizumab 1326244-10-3
Triumbelletin 131559-54-1
Futuximab 1310460-85-5
Parsatuzumab 1312797-14-0
Vofatamab 1312305-12-6
ML372 1331745-61-9
Opc 18750 128667-63-0
BW-1370U87 134476-36-1
LSD1-IN-30 1289575-45-6
Raxofelast 128232-14-4
Duligotuzumab 1314238-96-4
Ligelizumab 1322627-61-1
Seribantumab 1334296-12-6
Tigulixostat 1287766-55-5
Upacicalcet 1333218-50-0
Aprikalim 132562-26-6
dCeMM4 1281683-44-0
Lesopitron 132449-46-8
PLpro/RBD-IN-1 1282451-83-5
Irtemazole 129369-64-8
IMSs inhibitor S12 Perchlorate 1334529-08-6
Palmatine hydroxide 131-04-4
MK-8325 1334314-19-0
Modotuximab 1310460-86-6
Abrilumab 1342290-43-0
Demethylcantharidate disodium 129-67-9
Rocepafant 132579-32-9
Tazomeline 131987-54-7
20-HETE Intermediate 15 1286736-37-5
5-HT6/7 antagonist 1 131999-28-5
(Iso)-Samixogrel 133276-52-5
82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.